MECOM is a transcriptional regulator of the NF-κβ-mediated inflammatory response and an oncogene whose upregulation has been associated with many types of solid cancers in humans, including colorectal cancer and acute myeloid leukemia [65, 66]. Here, NFKB1 is linked to colorectal cancer.